Gene · 10344
Papers3,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors. | Nat Commun | 2023 | 37500647 | PubTator, text mining | PubMed |
| Editorial: Current trends and challenges in the assessment of suicidal behavior: a psychometric approach. | Front Psychiatry | 2023 | 37496687 | PubTator, text mining | PubMed |
| Short-range interactions between fibrocytes and CD8+ T cells in COPD bronchial inflammatory response. | Elife | 2023 | 37494277 | PubTator, text mining | PubMed |
| Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis. | Am J Rhinol Allergy | 2023 | 37491901 | PubTator, text mining | PubMed |
| Eosinophils as potential biomarkers in respiratory viral infections. | Front Immunol | 2023 | 37483591 | PubTator, text mining | PubMed |
| Gene set variation analysis-based aging and senescence score as a prognostic indicator and therapeutic guide in lung adenocarcinoma. | Front Genet | 2023 | 37470041 | PubTator, text mining | PubMed |
| The Different Features of Inflammatory Endotypes in Korean Patients With Chronic Rhinosinusitis. | Allergy Asthma Immunol Res | 2023 | 37469239 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses. | iScience | 2023 | 37456846 | PubTator, text mining | PubMed |
| Food allergy: cause or consequence of pediatric eosinophilic esophagitis? Potential implications of ultraprocessed foods in prevention and management. | Front Allergy | 2023 | 37456790 | PubTator, text mining | PubMed |
| A deep learning-based framework for predicting survival-associated groups in colon cancer by integrating multi-omics and clinical data. | Heliyon | 2023 | 37455955 | PubTator, text mining | PubMed |
| Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system. | Front Med (Lausanne) | 2023 | 37448794 | PubTator, text mining | PubMed |
| Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis. | Int J Mol Sci | 2023 | 37446281 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. | Cancers (Basel) | 2023 | 37444400 | PubTator, text mining | PubMed |
| A Case of Isotopic Response Presented with Eosinophilic Pustular Folliculitis. | Clin Cosmet Investig Dermatol | 2023 | 37441695 | PubTator, text mining | PubMed |
| Case report: Neonatal case of intrauterine gastrointestinal bleeding with suspected cow's milk allergy or neonatal transient eosinophilic colitis. | Front Pediatr | 2023 | 37441571 | PubTator, text mining | PubMed |
| Validation of Epigenetic Markers for the Prediction of Response to Topical Corticosteroid Treatment in Eosinophilic Esophagitis. | Clin Transl Gastroenterol | 2023 | 37439560 | PubTator, text mining | PubMed |
| Development and validation of asthma risk prediction models using co-expression gene modules and machine learning methods. | Sci Rep | 2023 | 37438356 | PubTator, text mining | PubMed |
| Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol. | BMJ Open | 2023 | 37429687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10344/papers?page=20